Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: Moderate Risk
Methylphenidat carries a moderate risk profile. Acute and chronic risks depend significantly on dose, frequency, route of administration, and individual predispositions.
The following substances carry an elevated risk of adverse interactions with Methylphenidat. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
medical
Nur nach ärztlicher Verschreibung für ADHS/Narkolepsie — nicht für kognitive Enhancement-Zwecke ohne Diagnose
combinations
Keine Kombination mit MAO-Hemmern — hypertensive Krise und Serotonin-Syndrom möglich
health
Herzerkrankungen, Bluthochdruck, Hyperthyreose: kontraindiziert ohne kardiologische Abklärung
harm_reduction
Missbrauch (Schnupfen, i.v.) erhöht Suchtpotenzial und Toxizität erheblich — nur oral einnehmen
harm_reduction
Schlaf priorisieren — Methylphenidat-induzierter Schlafmangel verstärkt negative Effekte auf Kognition
health
Bei Kindern: regelmäßige Wachstums- und Gewichtskontrollen durch Arzt
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.